Outcome of Extra-Ordinary General Meeting of the Company held on today i.e. Tuesday, 3rd June, 2025 at 03:02 P.M. through VC/OAVM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies held an Extra-Ordinary General Meeting (EGM) on 3rd June 2025 via video conferencing, running a brief 8 minutes from 3:02 PM to 3:10 PM. Chaired by Managing Director Bhumishth Patel, the meeting put four resolutions to e-voting: increasing authorised share capital and altering the capital clause of the Memorandum of Association (ordinary resolution), two separate preferential allotments of equity shares on a non-cash basis (special resolutions), and alteration of the object clause of the MoA (special resolution). The chairperson confirmed quorum was present and the e-voting results will be announced within two working days and intimated to BSE.
The proposed preferential equity issuances and authorised capital hike suggest the company is preparing to onboard new investors or strategic partners, which could dilute existing shareholders. The object clause change indicates a possible pivot or addition to the company's business activities. Investors should watch for the e-voting results expected within 2 working days.